3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myeloproliferative Disorders
4
Primary Myelofibrosis
2
Myelodysplastic Syndromes
2
Leukemia, Myelomonocytic, Chronic
2
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thrombocytosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Leukemia, Prolymphocytic, T-Cell
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Inhibition, Psychological
1
Hodgkin Disease
1
Graft vs Host Disease
1
B-cell Malignancies
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
pembrolizumab
59
Cisplatin
45
Cetuximab
29
Radiotherapy
26
Carboplatin
25
Docetaxel
17
Paclitaxel
16
Nivolumab
16
Surveys and Questionnaires
15
Radiotherapy, Intensity-Modulated
13
Fluorouracil
12
Drug Therapy
12
Blood Specimen Collection
11
Standard of Care
8
tislelizumab
7
Radiation
7
cemiplimab
6
atezolizumab
6
Chemoradiotherapy
6
toripalimab
5
Surgical Procedures, Operative
5
Cyclophosphamide
5
130-nm albumin-bound paclitaxel
5
nimotuzumab
4
fludarabine
4
durvalumab
4
dostarlimab
4
Afatinib
4
palbociclib
3
niraparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
itacitinib
×
1 year
×
Clear all
No trials found.